Literature DB >> 26245826

Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2.

Juan Du1, Yan Zhu2, Yu-Lin Zhang1, Sha Li1, Jing Huang1, Xiao-Hua Luo3, Lin Liu4.   

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal-dominantly inherited vascular-malformation syndrome associated with gene mutations including ENG, ACVRL1 and SMAD4 gene. Clinically indistinguishable HHT1 and HHT2 are caused by mutations in ENG and ACVRL1 gene, respectively. Generally, pulmonary arteriovenous malformations (PAVMs) and pulmonary arterial hypertension (PAH) are rare manifestations of HHT related to ACVRL1 gene mutations. We described a female patient with HHT2 whose clinical features included epistaxis, mucocutaneous telangiectases, systemic AVMs and PAH. She also suffered from severe iron deficiency anemia and recurrent heart failure. A genetic mutation analysis disclosed a missense mutation in exon 7 of ACVRL1 gene in this patient and her daughter. A nonsense mutation in exon 7 of ACVRL1 gene was detected in her brother and her niece. This case supports that PAVMs and PAH can be rare manifestations of HHT2 patients.

Entities:  

Keywords:  ACVRL1 gene; Epistaxis; Hereditary hemorrhagic telangiectasia; Pulmonary arteriovenous malformations

Mesh:

Substances:

Year:  2015        PMID: 26245826     DOI: 10.1007/s11239-015-1253-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  26 in total

1.  Report on the workshop on Hereditary Hemorrhagic Telangiectasia, July 10-11, 1997.

Authors:  D A Marchuk; A E Guttmacher; J A Penner; P Ganguly
Journal:  Am J Med Genet       Date:  1998-03-19

2.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.

Authors:  Laurent David; Christine Mallet; Sabine Mazerbourg; Jean-Jacques Feige; Sabine Bailly
Journal:  Blood       Date:  2006-10-26       Impact factor: 22.113

3.  Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease.

Authors:  Giovanna Pasculli; Francesco Resta; Edoardo Guastamacchia; Leonardo Di Gennaro; Patrizia Suppressa; Carlo Sabbà
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

4.  Worsening pulmonary hypertension after resection of arteriovenous fistula.

Authors:  B A Rodan; J D Goodwin; J T Chen; C E Ravin
Journal:  AJR Am J Roentgenol       Date:  1981-10       Impact factor: 3.959

5.  A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12.

Authors:  D W Johnson; J N Berg; C J Gallione; K A McAllister; J P Warner; E A Helmbold; D S Markel; C E Jackson; M E Porteous; D A Marchuk
Journal:  Genome Res       Date:  1995-08       Impact factor: 9.043

6.  A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7.

Authors:  Pinar Bayrak-Toydemir; Jamie McDonald; Nurten Akarsu; Reha M Toydemir; Fernanda Calderon; Timur Tuncali; Wei Tang; Franklin Miller; Rong Mao
Journal:  Am J Med Genet A       Date:  2006-10-15       Impact factor: 2.802

7.  Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

Authors:  R C Trembath; J R Thomson; R D Machado; N V Morgan; C Atkinson; I Winship; G Simonneau; N Galie; J E Loyd; M Humbert; W C Nichols; N W Morrell; J Berg; A Manes; J McGaughran; M Pauciulo; L Wheeler
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

8.  Hereditary haemorrhagic telangiectasia: mutation detection, test sensitivity and novel mutations.

Authors:  N L Prigoda; S Savas; S A Abdalla; B Piovesan; D Rushlow; K Vandezande; E Zhang; H Ozcelik; B L Gallie; M Letarte
Journal:  J Med Genet       Date:  2006-05-11       Impact factor: 6.318

9.  Update on molecular diagnosis of hereditary hemorrhagic telangiectasia.

Authors:  Jennifer Richards-Yutz; Kathleen Grant; Elizabeth C Chao; Susan E Walther; Arupa Ganguly
Journal:  Hum Genet       Date:  2010-04-23       Impact factor: 4.132

10.  Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.

Authors:  Barbara Girerd; David Montani; Florence Coulet; Benjamin Sztrymf; Azzeddine Yaici; Xavier Jaïs; David Tregouet; Abilio Reis; Valérie Drouin-Garraud; Alain Fraisse; Olivier Sitbon; Dermot S O'Callaghan; Gérald Simonneau; Florent Soubrier; Marc Humbert
Journal:  Am J Respir Crit Care Med       Date:  2010-01-07       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.